Biotechnology Stocks
Some of the top Biotechnology stocks now:
Olema Pharmaceuticals, Inc. Common Stock (OLMA -1.03%), CorMedix Inc. (CRMD +2.10%), Silence Therapeutics Plc American Depository Share (SLN +3.23%), DBV Technologies S.A. American Depositary Shares (DBVT +2.37%).
The table below shows a total of 593 Biotechnology stocks, each contributes to the landscape of the Biotechnology industry. You can easily customize the table by ranking stocks based on price, volume or market cap according to your specific investing preferences.
| Symbol | Name | Price | % (1D) | Volume | Market Cap | Price Chart (1D) â–¾ | |
|---|---|---|---|---|---|---|---|
|
Olema Pharmaceuticals, Inc. Common Stock
|
6.73
|
-1.03% |
426.24K |
588.86M |
|
||
|
CorMedix Inc.
|
7.545
|
+2.10% |
856.11K |
588.09M |
|
||
|
Silence Therapeutics Plc American Depository Share
|
9.27
|
+3.23% |
456.56K |
576.17M |
|
||
|
DBV Technologies S.A. American Depositary Shares
|
9.08
|
+2.37% |
244.14K |
570.66M |
|
||
|
Sagimet Biosciences Inc. Series A Common Stock
|
8.035
|
+6.49% |
734.81K |
569.75M |
|
||
|
Electra Therapeutics, Inc. Common stock
|
8.94
|
+3.83% |
521.07K |
561.14M |
|
||
|
Valneva SE American Depositary Shares
|
5.83
|
+3.00% |
3,244 |
552.82M |
|
||
|
PUMA BIOTECHNOLOGY INC
|
10.63
|
+4.26% |
135.43K |
548.98M |
|
||
|
Faeth Therapeutics, Inc. Common Stock
|
21.17
|
+5.85% |
93,219 |
547.04M |
|
||
|
Shattuck Labs, Inc. Common Stock
|
5.43
|
+1.88% |
293.85K |
544.97M |
|
||
|
Bright Minds Biosciences Inc. Common Stock
|
53.91
|
+6.31% |
63,161 |
531.77M |
|
||
|
CytomX Therapeutics, Inc.
|
2.395
|
+7.40% |
1.19M |
521.87M |
|
||
|
Aclaris Therapeutics, Inc.
|
3.445
|
+1.92% |
1.07M |
507.10M |
|
||
|
BlossomHill Therapeutics, Inc. Common Stock
|
15.26
|
-1.42% |
170.17K |
485.04M |
|
||
|
Monopar Therapeutics Inc. Common Stock
|
72.04
|
-1.45% |
57,577 |
483.54M |
|
||
|
Neurogene, Inc. Common Stock
|
24.12
|
+8.75% |
173.03K |
482.67M |
|
||
|
YD Bio Limited Ordinary Shares
|
6.80
|
+6.92% |
27,937 |
481.73M |
|
||
|
Crescent Biopharma, Inc. Common Stock
|
12.66
|
+0.64% |
97,808 |
470.28M |
|
||
|
Allogene Therapeutics, Inc. Common Stock
|
1.3499
|
+3.84% |
2.98M |
466.38M |
|
||
|
Arvinas, Inc
|
7.125
|
+4.47% |
231.79K |
465.88M |
|
||
|
Oculis Holding AG Ordinary shares
|
7.50
|
+4.60% |
171.71K |
461.91M |
|
||
|
REGENXBIO Inc.
|
6.985
|
+1.53% |
417.85K |
461.10M |
|
||
|
Autolus Therapeutics plc American Depositary Share
|
1.715
|
+1.48% |
1.04M |
456.47M |
|
||
|
Entera Bio Ltd. Ordinary Shares
|
2.62
|
+4.80% |
866.61K |
455.45M |
|
||
|
Altimmune, Inc. Common Stock
|
2.315
|
+0.22% |
2.24M |
450.31M |
|
||
|
MapLight Therapeutics, Inc. Common Stock
|
8.02
|
+2.69% |
373.78K |
445.72M |
|
||
|
DiaMedica Therapeutics Inc. Common Stock
|
8.225
|
+7.38% |
89,915 |
443.54M |
|
||
|
Eupraxia Pharmaceuticals Inc. Common Stock
|
6.675
|
+1.29% |
199.34K |
441.04M |
|
||
|
PROTHENA CORP PUBLIC LTD CO
|
8.47
|
+1.19% |
146.39K |
434.82M |
|
||
|
Ovid Therapeutics Inc. Common Stock
|
2.22
|
+1.37% |
584.20K |
433.56M |
|
||
|
Assembly Biosciences, Inc
|
20.62
|
+0.45% |
60,589 |
419.88M |
|
||
|
Tectonic Therapeutic, Inc. Common Stock
|
21.40
|
+2.10% |
65,959 |
418.36M |
|
||
|
Capricor Therapeutics Inc
|
7.08
|
+7.44% |
1.74M |
411.62M |
|
||
|
Eikon Therapeutics, Inc. Common Stock
|
7.555
|
+7.77% |
389.48K |
409.22M |
|
||
|
Zura Bio Limited Class A Ordinary Shares
|
4.255
|
-3.51% |
3.00M |
407.75M |
|
||
|
AgomAb Therapeutics NV American Depositary Shares
|
8.1989
|
-5.65% |
40,455 |
403.78M |
|
||
|
ARS Pharmaceuticals, Inc. Common Stock
|
4.045
|
+2.93% |
1.17M |
402.26M |
|
||
|
Scribe Therapeutics Inc. Common Stock
|
20.77
|
+8.63% |
391.97K |
393.21M |
|
||
|
Rezolute, Inc. Common Stock (NV)
|
4.025
|
-4.85% |
1.35M |
389.31M |
|
||
|
Galectin Therapeutics Inc.
|
3.785
|
+3.98% |
64,114 |
381.72M |
|
||
|
Atea Pharmaceuticals, Inc. Common Stock
|
4.635
|
+0.11% |
69,705 |
371.75M |
|
||
|
TRex Bio, Inc. Common stock
|
13.50
|
-0.74% |
398.83K |
370.52M |
|
||
|
Editas Medicine, Inc. Common Stock
|
2.40
|
+5.73% |
885.02K |
368.59M |
|
||
|
Kyverna Therapeutics, Inc. Common Stock
|
5.905
|
+3.87% |
435.86K |
365.19M |
|
||
|
Fennec Pharmaceuticals Inc. Common Stock
|
10.28
|
+3.01% |
38,406 |
360.49M |
|
||
|
Turn Therapeutics Inc. Common Stock
|
11.77
|
+5.94% |
15,966 |
357.43M |
|
||
|
Indaptus Therapeutics, Inc. Common Stock
|
2.6797
|
+21.25% |
894.43K |
357.05M |
|
||
|
Orchestra BioMed Holdings, Inc. Ordinary Shares
|
5.72
|
+1.42% |
92,359 |
343.80M |
|
||
|
Relmada Therapeutics, Inc. Common Stock
|
3.205
|
-1.08% |
441.72K |
341.88M |
|
||
|
C4 Therapeutics, Inc.
|
2.765
|
+5.94% |
1.20M |
340.16M |
|
||
|
Enanta Pharmaceuticals, Inc
|
11.50
|
+2.86% |
58,878 |
334.94M |
|
||
|
Opus Genetics, Inc. Common Stock
|
3.985
|
-2.80% |
1.34M |
331.54M |
|
||
|
Arcturus Therapeutics Holdings Inc. Common Stock
|
11.08
|
-0.36% |
256.03K |
314.93M |
|
||
|
Cypherpunk Technologies Inc. Common Stock
|
2.875
|
+9.73% |
9.59M |
309.82M |
|
||
|
Agenus Inc.
|
6.8055
|
+4.70% |
450.90K |
307.35M |
|
||
|
ProKidney Corp. Class A Ordinary Shares
|
1.455
|
-1.02% |
482.84K |
303.99M |
|
||
|
Benitec Biopharma Inc. Common Stock
|
8.47
|
+2.17% |
51,496 |
295.46M |
|
||
|
Artiva Biotherapeutics, Inc. Common Stock
|
6.0007
|
+1.53% |
286.47K |
293.37M |
|
||
|
Contineum Therapeutics, Inc. Class A Common Stock
|
7.78
|
-4.42% |
325.92K |
292.69M |
|
||
|
Surrozen, Inc. Common
|
24.70
|
+4.00% |
128.53K |
290.31M |
|
||
|
Fulcrum Therapeutics, Inc. Common Stock
|
3.68
|
+0.27% |
458.22K |
281.09M |
|
||
|
Ocugen, Inc. Common Stock
|
0.8124
|
-3.43% |
3.55M |
275.48M |
|
||
|
Nautilus Biotechnolgy, Inc. Common Stock
|
2.1309
|
-1.35% |
6.16M |
271.17M |
|
||
|
Abeona Therapeutics Inc. Common Stock
|
4.71
|
+8.03% |
711.91K |
269.34M |
|
||
|
Clinuvel Pharmaceuticals Limited American Depositary Shares
|
5.30
|
-2.61% |
3,593 |
267.58M |
|
||
|
Prelude Therapeutics Incorporated
|
3.35
|
+3.72% |
168.49K |
267.34M |
|
||
|
Palisade Bio, Inc. Common Stock
|
1.515
|
+2.36% |
1.02M |
264.02M |
|
||
|
Cabaletta Bio, Inc. Common Stock
|
1.555
|
-4.01% |
2.08M |
263.64M |
|
||
|
Century Therapeutics, Inc. Common Stock
|
1.45
|
+5.07% |
396.82K |
262.56M |
|
||
|
EyePoint, Inc. Common Stock
|
3.045
|
+1.16% |
1.12M |
262.52M |
|
||
|
Inhibikase Therapeutics, Inc. Common Stock
|
1.845
|
+2.50% |
184.00K |
257.44M |
|
||
|
Vanda Pharmaceuticals Inc.
|
4.245
|
+0.59% |
543.41K |
256.66M |
|
||
|
Rocket Pharmaceuticals, Inc. Common Stock
|
2.33
|
+5.43% |
847.12K |
255.77M |
|
||
|
X4 Pharmaceuticals, Inc. Common Stock
|
2.565
|
+4.69% |
211.26K |
254.31M |
|
||
|
Vicore Pharma Holding AB American Depositary Shares
|
8.985
|
-1.05% |
25,054 |
253.06M |
|
||
|
Bicycle Therapeutics plc American Depositary Shares
|
3.565
|
+1.57% |
212.68K |
249.52M |
|
||
|
Lineage Cell Therapeutics, Inc.
|
0.9656
|
+5.24% |
525.27K |
244.19M |
|
||
|
AC Immune SA
|
2.435
|
+1.46% |
54,310 |
242.10M |
|
||
|
Vogenx Inc Common Stock
|
16.10
|
-3.94% |
94,222 |
239.17M |
|
||
|
Q32 Bio Inc. Common Stock
|
7.93
|
-1.00% |
288.65K |
236.07M |
|
||
|
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
2.93
|
+0.86% |
281.41K |
234.91M |
|
||
|
Immuneering Corporation Class A Common Stock
|
3.625
|
+5.99% |
507.71K |
234.53M |
|
||
|
SAB Biotherapeutics, Inc. Common Stock
|
2.55
|
+2.41% |
417.65K |
232.02M |
|
||
|
Fate Therapeutics, Inc.
|
1.9275
|
-0.64% |
545.97K |
230.95M |
|
||
|
Lexeo Therapeutics, Inc. Common Stock
|
2.7692
|
+5.29% |
684.69K |
227.32M |
|
||
|
Sol-Gel Technologies Ltd. Ordinary Shares
|
68.95
|
-0.79% |
10,867 |
225.74M |
|
||
|
Greenwich LifeSciences, Inc.
|
15.19
|
-1.36% |
41,287 |
222.96M |
|
||
|
Keros Therapeutics, Inc. Common Stock
|
11.11
|
+0.54% |
40,771 |
220.28M |
|
||
|
Protalix BioTherapeutics, Inc. Common Stock
|
2.715
|
+4.02% |
628.91K |
218.75M |
|
||
|
CAMP4 Therapeutics Corporation Common Stock
|
3.47
|
+1.17% |
21,104 |
217.75M |
|
||
|
InflaRx N.V. Common Stock
|
1.46
|
-1.35% |
293.80K |
215.16M |
|
||
|
Alector, Inc. Common Stock
|
1.925
|
+2.39% |
1.15M |
214.94M |
|
||
|
Evommune, Inc.
|
5.885
|
+1.99% |
388.44K |
213.58M |
|
||
|
MacroGenics, Inc.
|
3.35
|
+1.21% |
329.10K |
213.40M |
|
||
|
Zentalis Pharmaceuticals, Inc. Common Stock
|
2.24
|
-3.45% |
1.49M |
212.07M |
|
||
|
Larimar Therapeutics, Inc. Common Stock
|
2.015
|
-3.59% |
715.87K |
209.32M |
|
||
|
ProQR Therapeutics N.V. Ordinary Shares
|
1.465
|
-0.34% |
437.79K |
206.74M |
|
||
|
Lyell Immunopharma, Inc. Common Stock
|
8.34
|
+4.38% |
153.89K |
204.37M |
|
||
|
Compugen Ltd
|
2.0999
|
+5.00% |
138.11K |
198.92M |
|
||
|
Cartesian Therapeutics, Inc. Common Stock
|
6.54
|
+3.15% |
23,957 |
197.87M |
|
||
|
Invivyd, Inc. Common Stock
|
0.6464
|
+6.35% |
2.37M |
190.53M |
|
||
|
Sutro Biopharma, Inc.
|
11.30
|
+7.41% |
150.48K |
187.37M |
|
||
|
Sionna Therapeutics, Inc. Common Stock
|
4.1301
|
+0.98% |
421.34K |
186.73M |
|
||
|
Eledon Pharmaceuticals, Inc. Common Stock
|
2.265
|
+0.67% |
378.10K |
184.06M |
|
||
|
Upstream Bio, Inc. Common Stock
|
3.35
|
-2.05% |
616.44K |
183.48M |
|
||
|
Entrada Therapeutics, Inc. Common Stock
|
4.67
|
+2.64% |
141.33K |
181.83M |
|
||
|
Alpha Cognition Inc. Common Stock
|
8.185
|
-5.38% |
69,870 |
178.25M |
|
||
|
Oramed Pharmaceuticals Inc.
|
4.205
|
+1.57% |
48,126 |
174.92M |
|
||
|
PepGen Inc. Common Stock
|
2.525
|
+8.84% |
264.27K |
174.88M |
|
||
|
Whitehawk Therapeutics, Inc. Common Stock
|
3.055
|
+2.86% |
210.93K |
174.16M |
|
||
|
NervGen Pharma Corp. Common stock
|
1.605
|
+2.56% |
239.47K |
172.57M |
|
||
|
Precision BioSciences, Inc. Common Stock
|
6.085
|
+0.91% |
108.04K |
167.96M |
|
||
|
Innate Pharma S.A. ADS
|
1.49
|
+4.20% |
3,835 |
166.43M |
|
||
|
Coherus Oncology, Inc. Common Stock
|
1.055
|
+0.48% |
526.63K |
163.00M |
|
||
|
Yarrow Bioscience, Inc. Common Stock
|
18.90
|
+1.61% |
105.57K |
159.50M |
|
||
|
Compass Therapeutics, Inc. Common Stock
|
0.8762
|
-0.32% |
1.72M |
157.79M |
|
||
|
MediWound Ltd.
|
12.00
|
+0.75% |
25,840 |
154.92M |
|
||
|
Adagene Inc. American Depositary Shares
|
2.30
|
+0.44% |
173.05K |
154.43M |
|
||
|
Veraxa Biotech AG Ordinary Shares
|
1.09
|
-1.80% |
54,610 |
154.13M |
|
||
|
Canton Strategic Holdings, Inc. Common Stock
|
1.90
|
+3.54% |
735.72K |
151.39M |
|
||
|
NovaBridge Biosciences American Depositary Shares
|
1.29
|
+0.78% |
307.04K |
149.19M |
|
||
|
Pyxis Oncology, Inc. Common Stock
|
1.785
|
-0.28% |
228.44K |
148.88M |
|
||
|
Jyong Biotech Ltd. Ordinary Shares
|
1.99
|
-2.93% |
105.80K |
147.72M |
|
||
|
Satellos Bioscience Inc. Common Stock
|
6.87
|
+3.62% |
66,515 |
145.76M |
|
||
|
Codexis, Inc.
|
1.33
|
+3.10% |
406.22K |
145.64M |
|
||
|
Protara Therapeutics, Inc. Common Stock
|
2.45
|
-1.21% |
445.49K |
144.78M |
|
||
|
Molecular Partners AG American Depositary Shares
|
3.65
|
-0.54% |
3,304 |
139.81M |
|
||
|
Anavex Life Sciences
|
1.50
|
+0.67% |
311.93K |
139.05M |
|
||
|
Nkarta, Inc. Common Stock
|
1.93
|
-4.93% |
1.01M |
138.24M |
|
||
|
AN2 Therapeutics, Inc. Common Stock
|
3.57
|
+0.85% |
151.32K |
134.72M |
|
||
|
Atrium Therapeutics, Inc. Common Stock
|
7.765
|
+1.11% |
52,997 |
132.83M |
|
||
|
Korro Bio, Inc. Common Stock
|
8.935
|
+0.62% |
56,063 |
131.57M |
|
||
|
Cue Biopharma, Inc.
|
18.08
|
-2.80% |
119.80K |
131.34M |
|
||
|
Tiziana Life Sciences Ltd. Common Shares
|
1.03
|
-1.90% |
125.12K |
131.08M |
|
||
|
ALX Oncology Holdings Inc. Common Stock
|
0.9425
|
+5.34% |
1.72M |
130.33M |
|
||
|
Voyager Therapeutics, Inc. Common Stock
|
2.035
|
+1.24% |
387.03K |
125.39M |
|
||
|
Acumen Pharmaceuticals, Inc. Common Stock
|
1.71
|
-2.01% |
325.30K |
123.66M |
|
||
|
Outlook Therapeutics, Inc. Common Stock
|
0.5001
|
+6.35% |
3.89M |
121.74M |
|
||
|
NRX Pharmaceuticals, Inc. Common Stock
|
2.695
|
+4.05% |
826.58K |
116.68M |
|
||
|
Spruce Biosciences, Inc. Common Stock
|
40.56
|
+4.05% |
27,636 |
116.57M |
|
||
|
Kazia Therapeutics Limited American Depositary Shares
|
7.47
|
+10.01% |
248.39K |
116.15M |
|
||
|
Humacyte, Inc. Common Stock
|
0.4146
|
+17.09% |
14.56M |
115.18M |
|
||
|
Seer, Inc. Class A Common Stock
|
2.07
|
-0.48% |
84,440 |
114.62M |
|
||
|
TuHURA Biosciences, Inc. Common Stock
|
1.78
|
+1.14% |
56,067 |
113.43M |
|
||
|
Foghorn Therapeutics Inc. Common Stock
|
1.905
|
+2.97% |
128.60K |
113.13M |
|
||
|
Armata Pharmaceuticals, Inc. Common Stock
|
3.04
|
+9.35% |
60,995 |
113.03M |
|
||
|
enGene Therapeutics Inc. Common Stock
|
1.665
|
+6.73% |
534.76K |
111.58M |
|
||
|
Genelux Corporation Common Stock
|
2.46
|
+6.03% |
180.76K |
111.30M |
|
||
|
vTv Therapeutics Inc. Class A Common Stock
|
28.09
|
+2.07% |
14,550 |
111.07M |
|
||
|
Tonix Pharmaceuticals Holding Corp.
|
6.47
|
+1.09% |
1.51M |
110.97M |
|
||
|
LENZ Therapeutics, Inc. Common Stock
|
3.52
|
+2.62% |
366.29K |
110.60M |
|
||
|
Cellectis S.A. American Depositary Shares
|
1.09
|
-2.68% |
55,071 |
109.80M |
|
||
|
Minerva Neurosciences, Inc
|
2.29
|
-2.55% |
71,907 |
109.34M |
|
||
|
Inovio Pharmaceuticals, Inc.
|
1.045
|
+5.98% |
1.28M |
108.05M |
|
||
|
Conexeu Sciences Inc. Common Stock
|
3.77
|
+3.43% |
341.41K |
106.34M |
|
||
|
Vivani Medical, Inc. Common Stock (DE)
|
1.155
|
-0.43% |
43,199 |
104.18M |
|
||
|
Coya Therapeutics, Inc. Common Stock
|
4.38
|
+4.78% |
103.45K |
102.75M |
|
||
|
Cibus, Inc. Class A Common Stock
|
1.325
|
-5.36% |
45,031 |
101.27M |
|
||
|
Unicycive Therapeutics, Inc. Common Stock
|
3.61
|
-2.43% |
435.36K |
100.56M |
|
||
|
PolyPid Ltd. Ordinary Shares
|
4.87
|
+0.83% |
97,977 |
98.92M |
|
||
|
Milestone Pharmaceuticals Inc. Common Shares
|
0.7934
|
+0.69% |
571.66K |
98.77M |
|
||
|
Immucell Corp
|
10.77
|
+0.19% |
7,174 |
97.82M |
|
||
|
Black Diamond Therapeutics, Inc. Common Stock
|
1.7007
|
+0.04% |
294.32K |
97.71M |
|
||
|
Atara Biotherapeutics, Inc
|
9.71
|
+1.57% |
10,681 |
97.47M |
|
||
|
Retension Pharmaceuticals, Inc. Common Stock
|
11.64
|
+0.09% |
77,190 |
96.98M |
|
||
|
Neuraxis, Inc.
|
7.72
|
+18.22% |
685.05K |
96.95M |
|
||
|
Polaryx Therapeutics, Inc. Common Stock
|
1.92
|
-2.54% |
27,892 |
95.70M |
|
||
|
PDS Biotechnology Corporation Common Stock
|
1.315
|
-6.74% |
8.64M |
95.30M |
|
||
|
Immunic, Inc. Common Stock
|
6.95
|
+4.35% |
142.73K |
94.83M |
|
||
|
Tenaya Therapeutics, Inc. Common Stock
|
0.4188
|
+7.25% |
4.01M |
93.91M |
|
||
|
Anixa Biosciences, Inc.
|
2.70
|
+1.69% |
140.02K |
93.86M |
|
||
|
OnKure Therapeutics, Inc. Class A Common Stock
|
2.20
|
-2.22% |
98,380 |
89.09M |
|
||
|
Rallybio Corporation Common Stock
|
16.70
|
-1.20% |
1,250 |
88.74M |
|
||
|
Corbus Pharmaceuticals Holdings, Inc.
|
4.49
|
+1.81% |
568.90K |
86.84M |
|
||
|
Equillium, Inc. Common Stock
|
1.355
|
+4.23% |
172.08K |
85.92M |
|
||
|
Aardvark Therapeutics, Inc. Common Stock
|
3.89
|
+0.26% |
35,500 |
85.13M |
|
||
|
Neumora Therapeutics, Inc. Common Stock
|
0.4352
|
+22.76% |
4.77M |
81.77M |
|
||
|
NeOnc Technologies Holdings, Inc. Common Stock
|
2.74
|
+3.01% |
58,364 |
78.93M |
|
||
|
Rani Therapeutics Holdings, Inc. Class A Common Stock
|
0.6809
|
+1.60% |
307.76K |
78.59M |
|
||
|
Nutriband Inc. Common Stock
|
6.44
|
+1.90% |
54,487 |
78.28M |
|
||
|
Pelthos Therapeutics Inc.
|
20.25
|
-0.20% |
44,471 |
77.53M |
|
||
|
Acrivon Therapeutics, Inc. Common Stock
|
1.77
|
+2.91% |
69,310 |
75.85M |
|
||
|
Telomir Pharmaceuticals, Inc. Common Stock
|
1.03
|
-1.90% |
45,812 |
75.83M |
|
||
|
Cardiff Oncology, Inc. Common Stock
|
0.9702
|
-0.33% |
243.37K |
75.48M |
|
||
|
ProMIS Neurosciences Inc. Common Shares (ON)
|
8.34
|
+0.66% |
11,710 |
74.79M |
|
||
|
OKYO Pharma Limited Ordinary Shares
|
1.415
|
+0.00% |
26,808 |
74.26M |
|
||
|
Oncolytics Biotech, Inc. Common Shares
|
0.5547
|
+3.07% |
557.76K |
72.73M |
|
||
|
Medicinova, Inc.
|
1.472
|
+0.14% |
25,340 |
72.45M |
|
||
|
Heron Therapeutics, Inc.
|
0.3734
|
+3.15% |
929.74K |
70.89M |
|
||
|
PMV Pharmaceuticals, Inc
|
1.31
|
+5.65% |
244.69K |
70.03M |
|
||
|
MAIA Biotechnology, Inc.
|
1.125
|
+0.45% |
225.80K |
69.46M |
|
||
|
Cognition Therapeutics, Inc. Common Stock
|
0.7281
|
-6.26% |
473.01K |
69.24M |
|
||
|
Champions Oncology, Inc.
|
4.82
|
+0.21% |
3,247 |
67.09M |
|
||
|
XBiotech Inc
|
2.178
|
+0.83% |
47,888 |
66.40M |
|
||
|
Spero Therapeutics, Inc. Common Stock
|
1.125
|
+0.45% |
162.50K |
65.51M |
|
||
|
Verrica Pharmaceuticals Inc. Common Stock
|
3.79
|
-1.04% |
17,661 |
65.11M |
|
||
|
OS Therapies Incorporated
|
1.39
|
-4.14% |
497.35K |
65.06M |
|
||
|
Fortress Biotech, Inc.
|
1.935
|
+1.84% |
111.00K |
64.53M |
|
||
|
MindWalk Holdings Corp. Common Stock
|
1.365
|
-0.36% |
108.58K |
64.31M |
|
||
|
Cingulate Inc. Common Stock
|
4.37
|
-4.38% |
122.80K |
63.55M |
|